MicroPure Genomics

Executive Summary

MicroPure Genomics is an early-stage biotechnology company based in San Diego, developing the µPrep sample preparation platform for DNA and RNA testing. The company's proprietary Electro-Hydrodynamic Purification (EHP) technology offers a beadless, pillarless, and gel-free solution to address front-end bottlenecks in genomic workflows. By simplifying and accelerating sample preparation, MicroPure aims to enable genomic analysis anytime, anywhere, by anyone, potentially opening up point-of-care and decentralized testing applications. Founded in 2018, the company remains in the early stages of development with no disclosed funding rounds, indicating a need for capital to advance commercialization. The platform has the potential to disrupt the molecular diagnostics market by reducing complexity and cost, though it faces competition from established sample preparation methods. If successful, MicroPure could significantly expand access to genomic testing, particularly in low-resource settings. However, as a pre-revenue startup, execution risk remains high, and the company must secure funding and validation partnerships to progress. The coming years will be critical for demonstrating technical feasibility and commercial viability.

Upcoming Catalysts (preview)

• Q4 2026Series A Financing Round60% success
• Q2 2027Strategic Partnership with Diagnostic Company40% success
• Q1 2027First Beta Launch of µPrep Platform50% success